Departments of Neurosurgery and Biostatistics, Washington University School of Medicine, St. Louis, Missouri.
Neurosurgery. 2013 Aug;73(2):224-31; discussion 231-2; quiz 232. doi: 10.1227/01.neu.0000430310.63702.3e.
Brain biopsies of superficial cortex are performed for diagnosis of neurological diseases, but preoperative predictors of successful diagnosis and risks are lacking.
We evaluated effectiveness and outcomes of superficial cortical biopsies and determined preoperative predictors of diagnosis, outcomes, morbidities, and mortality.
A single-institution retrospective analysis of 170 patients who underwent open brain biopsies of superficial cortex was performed. Clinical predictors of effectiveness and outcomes were determined using univariate/multivariate analyses and a system for risk-benefit stratification was created and tested.
Brain biopsies led to successful diagnosis in 122 of 170 (71.8%) and affected management in 97 of 170 (57.1%) cases. Factors increasing the odds of diagnostic pathology included age older than 45 years (odds ratio [OR]: 2.67, 95% confidence interval [CI]: 1.34-5.27, P < .01), previous cancer diagnosis (OR: 3.64, 95% CI: 1.69-7.85, P < .001), focal (OR: 3.90, 95% CI: 1.91-8.00, P < .001) and enhancing (OR: 5.03, 95% CI: 2.41-10.52, P < .001) lesions on magnetic resonance imaging, biopsy of specific lesions on magnetic resonance imaging (OR: 9.34, 95% CI: 4.29-20.33, P < .001), and use of intraoperative navigation (OR: 6.59, 95% CI: 3.04-14.28, P < .001). Brain biopsies led to symptomatic intracranial hemorrhage, seizures, other significant morbidities, and perioperative mortality in 12.4%, 16.2%, 37.1%, and 8% of cases, respectively. Risk of postoperative intracranial hemorrhage was increased by a history of aspirin use (OR: 2.51, 95% CI: 1.23-5.28, P < .05) and age older than 60 years (OR: 2.66, 95% CI: 1.36-5.18, P < .01).
Effectiveness and risk of morbidity/mortality can be estimated preoperatively for patients undergoing open brain biopsies of the superficial cortex. Older age and specific imaging characteristics increase the odds of diagnostic biopsy. Conversely, older age and aspirin use increases the risk of postoperative complications.
为了诊断神经疾病,会对大脑皮层进行浅层活检,但目前尚缺乏关于成功诊断和风险的术前预测指标。
我们评估了浅层皮质活检的效果和结果,并确定了诊断、结果、发病率和死亡率的术前预测指标。
对 170 例行开放性大脑浅层皮质活检的患者进行了单中心回顾性分析。使用单因素/多因素分析确定了有效性和结果的临床预测指标,并创建和测试了风险-效益分层系统。
在 170 例患者中,有 122 例(71.8%)的活检有助于明确诊断,有 97 例(57.1%)的活检影响了治疗方案。增加诊断病理学几率的因素包括年龄大于 45 岁(优势比 [OR]:2.67,95%置信区间 [CI]:1.34-5.27,P <.01)、既往癌症诊断(OR:3.64,95% CI:1.69-7.85,P <.001)、局灶性(OR:3.90,95% CI:1.91-8.00,P <.001)和增强(OR:5.03,95% CI:2.41-10.52,P <.001)磁共振成像(MRI)病变、MRI 特定病变活检(OR:9.34,95% CI:4.29-20.33,P <.001)和术中导航使用(OR:6.59,95% CI:3.04-14.28,P <.001)。大脑活检导致 12.4%的患者出现症状性颅内出血,16.2%的患者出现癫痫发作,37.1%的患者出现其他严重发病率,8%的患者出现围手术期死亡率。阿司匹林的使用史(OR:2.51,95% CI:1.23-5.28,P <.05)和年龄大于 60 岁(OR:2.66,95% CI:1.36-5.18,P <.01)增加了术后颅内出血的风险。
对于行开放性大脑浅层皮质活检的患者,可在术前估计其有效性和发病率/死亡率风险。年龄较大和特定的影像学特征增加了诊断性活检的几率。相反,年龄较大和使用阿司匹林会增加术后并发症的风险。